Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Diagn Microbiol Infect Dis ; 91(2): 126-129, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29477273

ABSTRACT

Organ donors and recipients are routinely screened for hepatitis C virus (HCV) infection, typically via anti-HCV detection. We analyze the utility of an alternative HCV core antigen (HCV-Ag) quantification system, the ARCHITECT HCV Ag Assay, in this setting. We simultaneously tested 315 samples from potential organ donors and recipients using two chemiluminescent microparticle immunoassays: ARCHITECT Anti-HCV and HCV Ag (Abbott, Germany). HCV-Ag was detected in 81 of the serum samples (25.71%) and anti-HCV in 87 (27.62%). Seventy-five of the HCV-Ag-positive samples were positive for anti-HCV (92.59%). Overall concordance between the two assays was 94.29%. Of the six HCV-Ag-positive/anti-HCV-negative patients, five had HCV-Ag values <32 fmol/L, and the sixth had a concentration of 477.50 fmol/L (viral load, 137,000 IU/mL). The HCV AG Assay detects HCV infections missed by the Anti-HCV Assay. Both markers should be used to screen for HCV infection in potential organ donors and recipients.


Subject(s)
Hepatitis Antibodies/blood , Hepatitis C/diagnosis , Tissue Donors , Transplant Recipients , Viral Core Proteins/blood , Adult , Female , Hepacivirus/isolation & purification , Humans , Immunoassay , Male , Middle Aged , Reproducibility of Results , Transplants/virology
2.
Enferm. infecc. microbiol. clín. (Ed. impr.) ; 33(9): 590-596, nov. 2015. tab
Article in English | IBECS | ID: ibc-144634

ABSTRACT

INTRODUCTION: MRSA population dynamics is undergoing significant changes, and for this reason it is important to know which clones are circulating in our nosocomial environment. MATERIALS AND METHODS: A total of 118 MRSA isolates were collected from clinical samples from patients with previous hospital or healthcare contact (named as hospital-onset MRSA (HO-MRSA)) during a one year period. Susceptibility testing was performed by disk diffusion and microdilution. The presence of resistance genes and virulence factors were tested by PCR. All isolates were typed by SCCmec, spa and agr typing. PFGE and MLST were applied to a selection of them. RESULTS: Eighty-three HO-MRSA isolates (70.3%) were resistant to any antibiotic included in the macrolide-lincosamide-streptogramin B group. Among these isolates, the M phenotype was the most frequent (73.5%). One hundred and seven of HO-MRSA isolates (90.7%) showed aminoglycoside resistance. The combination aac(6')-Ie-aph(2'')-Ia + ant(4')-Ia genes was the most frequent (22.4%). Tetracycline resistance rates in HO-MRSA isolates were low (3.4%), although a high level of mupirocin resistance was observed (25.4%). Most of the HO-MRSA isolates (approximately 90%) showed SCCmec type IVc and agr type II. Fifteen unrelated pulsotypes were identified. CC5 was the most prevalent (88.1%), followed by CC8 (5.9%), CC22 (2.5%), CC398 (2.5%) and CC1 (0.8%). CONCLUSION: CC5/ST125/t067 lineage was the most frequent. This lineage was related to aminoglycoside resistance, and to a lesser extent, with macrolide resistance. The presence of international clones as EMRSA-15 (CC22/ST22), European clones as CC5/ST228, community clones related to CC1 or CC8 and livestock associated clones, as CC398, were observed in a low percentage


INTRODUCCIÓN: Las dinámicas poblacionales de SARM están experimentando cambios significativos en los últimos tiempos. Por ello es importante conocer qué líneas clonales circulan en nuestro ambiente hospitalario. MATERIALES Y MÉTODOS: Durante un año, se seleccionaron 118 SARM de muestras clínicas de pacientes con contacto previo con el ambiente hospitalario (SARM de origen hospitalario [SARM-OH]). Las pruebas de sensibilidad se realizaron mediante difusión con discos y microdilución. La presencia de genes de resistencia y factores de virulencia fueron estudiados mediante PCR. Se estableció el tipo de SCCmec, spa y agr en todos los aislados, y en una selección se estudió su relación genética por PFGE y MLST. RESULTADOS: Ochenta y tres SARM-OH (70,3%) fueron resistentes a al menos un antibiótico del grupo de los macrólidos-lincosamidas-estreptograminas B. Entre estos, el fenotipo M fue el más frecuente (73,5%). Ciento siete aislamientos (90,7%) mostraron resistencia a aminoglucósidos. La combinación aac(6')-Ieaph( 2'')-Ia + ant(4')-Ia fue la más frecuente (22,4%). Las tasas de resistencia a tetraciclinas detectadas fueron bajas (3,4%). Se observó un 25,4% de resistencia de alto nivel a mupirocina. Aproximadamente un 90% de SARM-OH mostraron SCCmec tipo IVc y agr tipo II. Se identificaron 15 pulsotipos no relacionados. El CC5 fue el más prevalente (88,1%) seguido de CC8 (5,9%), CC22 (2,5%), CC398 (2,5%) y CC1 (0,8%). CONCLUSIÓN: La línea clonal CC5/ST125/t067 fue la más habitual. Esta línea se relacionó con resistencia a aminoglucósidos, y, en menor medida, con macrólidos. La presencia de clones internacionales como EMRSA-15 (CC22/ST22), clones europeos como CC5/ST228, clones comunitarios relacionados con CC1 o CC8 y clones asociados al ganado, como el CC398, se observaron en un bajo porcentaje


Subject(s)
Humans , Staphylococcal Infections/drug therapy , Drug Resistance, Bacterial/genetics , Methicillin-Resistant Staphylococcus aureus/pathogenicity , Microbial Sensitivity Tests , Clonal Evolution , Bacterial Typing Techniques/methods
3.
Enferm Infecc Microbiol Clin ; 33(9): 590-6, 2015 Nov.
Article in English | MEDLINE | ID: mdl-25749415

ABSTRACT

INTRODUCTION: MRSA population dynamics is undergoing significant changes, and for this reason it is important to know which clones are circulating in our nosocomial environment. MATERIALS AND METHODS: A total of 118 MRSA isolates were collected from clinical samples from patients with previous hospital or healthcare contact (named as hospital-onset MRSA (HO-MRSA)) during a one year period. Susceptibility testing was performed by disk diffusion and microdilution. The presence of resistance genes and virulence factors were tested by PCR. All isolates were typed by SCCmec, spa and agr typing. PFGE and MLST were applied to a selection of them. RESULTS: Eighty-three HO-MRSA isolates (70.3%) were resistant to any antibiotic included in the macrolide-lincosamide-streptogramin B group. Among these isolates, the M phenotype was the most frequent (73.5%). One hundred and seven of HO-MRSA isolates (90.7%) showed aminoglycoside resistance. The combination aac(6')-Ie-aph(2″)-Ia+ant(4')-Ia genes was the most frequent (22.4%). Tetracycline resistance rates in HO-MRSA isolates were low (3.4%), although a high level of mupirocin resistance was observed (25.4%). Most of the HO-MRSA isolates (approximately 90%) showed SCCmec type IVc and agr type II. Fifteen unrelated pulsotypes were identified. CC5 was the most prevalent (88.1%), followed by CC8 (5.9%), CC22 (2.5%), CC398 (2.5%) and CC1 (0.8%). CONCLUSION: CC5/ST125/t067 lineage was the most frequent. This lineage was related to aminoglycoside resistance, and to a lesser extent, with macrolide resistance. The presence of international clones as EMRSA-15 (CC22/ST22), European clones as CC5/ST228, community clones related to CC1 or CC8 and livestock associated clones, as CC398, were observed in a low percentage.


Subject(s)
Cross Infection/microbiology , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Staphylococcal Infections/microbiology , Adolescent , Adult , Aged , Aged, 80 and over , Anti-Bacterial Agents/pharmacology , Bacterial Typing Techniques , Child , Child, Preschool , Clone Cells , Cross Infection/epidemiology , Drug Resistance, Multiple, Bacterial/genetics , Female , Genes, Bacterial , Humans , Infant , Male , Methicillin-Resistant Staphylococcus aureus/drug effects , Methicillin-Resistant Staphylococcus aureus/genetics , Microbial Sensitivity Tests , Middle Aged , Multilocus Sequence Typing , Staphylococcal Infections/epidemiology , Virulence Factors/genetics , Young Adult
4.
Int J Med Microbiol ; 303(8): 553-7, 2013 Dec.
Article in English | MEDLINE | ID: mdl-23999104

ABSTRACT

During the 30 months of surveillance period, 85 pAmpC-producing isolates were detected (prevalence 0.56% overall): blaCMY-2 gene in 70 E. coli, 2 K. pneumoniae and 6 P. mirabilis isolates; and the blaDHA-1 gene in 4 E. coli and 3 K. pneumoniae. In 8.23% of them, other ß-lactamases (predominantly OXA-1) were identified. All pAmpC-producing isolates were susceptible to carbapenems, whereas high resistance to nalidixic acid, ciprofloxacin and trimethoprim-sulfamethoxazole was observed among pAmpC-producing isolates (80%, 60%, and 44.7%, respectively). In hospital patients, predisposing factors such as prior antibiotic use, previous hospitalization, presence of an indwelling device, invasive urinary tract procedures and mechanical ventilation were observed. In the community setting, urinary tract infection was the most common type of infection related to pAmpC-producing isolates. A wide heterogeneity of clones was found among our E. coli isolates by PFGE, suggesting that this mechanism of resistance is not due to the dissemination of a clonal strain. Surveillance of these resistance mechanisms in the community is thus needed. Awareness of pAmpC dynamic is required to prevent introduction into hospitals and to control the spread of this emerging resistance within the community.


Subject(s)
Bacterial Proteins/genetics , Drug Resistance, Bacterial , Enterobacteriaceae Infections/microbiology , Enterobacteriaceae/classification , Enterobacteriaceae/enzymology , Molecular Typing , Plasmids , beta-Lactamases/genetics , Aged , Aged, 80 and over , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/metabolism , Community-Acquired Infections/epidemiology , Community-Acquired Infections/microbiology , Cross Infection/epidemiology , Cross Infection/microbiology , Electrophoresis, Gel, Pulsed-Field , Enterobacteriaceae/drug effects , Enterobacteriaceae/genetics , Enterobacteriaceae Infections/epidemiology , Escherichia coli , Female , Humans , Male , Middle Aged , Molecular Epidemiology , beta-Lactamases/metabolism
5.
Rev. esp. quimioter ; 25(2): 89-99, jun. 2012.
Article in Spanish | IBECS | ID: ibc-100506

ABSTRACT

Las β-lactamasas AmpC pueden hidrolizar penicilinas, cefamicinas, oximinocefalosporinas y monobactams, pero no son activas frente a cefalosporinas de cuarta generación y carbapenémicos. Los genes blaAmpC, que se encuentran en el cromosoma de algunos bacilos gramnegativos, se han integrado en elementos genéticos transferibles, lo que ha permitido su difusión a microorganismos que carecen de forma natural de ampC cromosómico o lo expresan a bajo nivel. La prevalencia de las infecciones causadas por bacterias productoras de AmpC plasmídica (pAmpC) varía en función del tipo de enzima y la localización geográfica, siendo blaCMY-2 la enzima de distribución más universal. Los aislados clínicos productores de pAmpC son con frecuencia resistentes a otros antimicrobianos, lo que reduce de manera importante las opciones terapéuticas. Se describen los métodos fenotípicos y genotípicos que permiten su detección y se analiza el papel que pueden desempeñar diferentes antimicrobianos en el tratamiento de las infecciones que producen. Este mecanismo emergente de resistencia requiere detectar y vigilar su evolución en los aislados clínicos y evaluar la sensibilidad in vitro y la eficacia clínica de otras opciones terapéuticas(AU)


AmpC β-lactamases can hydrolyze penicillins, oxyimino-, 7-α-methoxycephalosporins and monobactams. Susceptibility to cefepime or cefpirome is little affected and is unchanged for carbapenems. Originally such genes are thought to have been mobilized to mobile genetic elements from the chromosomal ampC genes from members of Enterobacteriaceae facilitating their spread and now they can appear in bacterial lacking or poorly expressing a chromosomal ampC gene. The prevalence of infection by plasmid mediated AmpC (pAmpC) varies depending on the type of enzyme and geographical location and blaCMY-2 is the most frequently detected worldwide. Typically, pAmpC producing isolates are associated with resistance to multiple antibiotics making the selection of an effective antibiotic difficult. Phenotypic and molecular methods to detect pAmpC are described and the role of different antibiotics in the treatment of these infections is examined. Surveillance studies about the evolution of this emerging resistant mechanism are important in clinical isolates. Evaluate the in vitro susceptibility of these isolates and the clinical efficacy of other therapeutic options is required(AU)


Subject(s)
Humans , Male , Female , Ambulatory Care , Emergency Medicine/methods , beta-Lactamases/therapeutic use , 3',5'-Cyclic-AMP Phosphodiesterases/therapeutic use , Infections/drug therapy , Cloxacillin/therapeutic use , Fosfomycin/therapeutic use , beta-Lactamases/pharmacology , Carbapenems/metabolism , Carbapenems/pharmacology , Carbapenems/pharmacokinetics
6.
Int Microbiol ; 13(3): 135-41, 2010 Sep.
Article in English | MEDLINE | ID: mdl-20890847

ABSTRACT

Mutations in quinolone targets were studied together with quinolone efflux pump activation and plasmid-mediated quinolone resistance determinants in nalidixic-acid-resistant isolates of Aeromonas caviae and Aeromonas veronii. Among 135 clinical Aeromonas spp. isolated from stools of patients with gastrointestinal symptoms, 40 nalidixic acid-resistant strains belonging to A. caviae and A. veronii were selected and their susceptibility to different quinolones (ciprofloxacin, norfloxacin, ofloxacin) further evaluated. Susceptibility to nalidixic acid and ciprofloxacin in the presence/absence of Phe- Arg-ß-naphthylamide was also determined. The 16 nalidixic-acid-resistant strains identified as A. caviae were more resistant than the 24 A. veronii bv. sobria strains to ciprofloxacin, norfloxacin, and ofloxacin. All strains showed a mutation (single or double) at position 83 of the QRDR sequence of gyrA, with Ser-83 → Ile as the most frequent substitution. By contrast, no mutations were found at position 87 of gyrA. Double substitutions (GyrA-ParC) were detected in 50% of A. veronii bv. sobria isolates and in 43.75% of A. caviae strains. Both species showed decreases in the MICs of ciprofloxacin. A qnrS gene was found in an A. caviae strain. Thus, in the two species of nalidixic-acid-resistant Aeromonas isolates examined, resistance mediated by efflux pumps contributed only slightly to ciprofloxacin resistance. While two isolates were positive for the aac(6')-Ib gene, no -cr variants were detected.


Subject(s)
Aeromonas/drug effects , Anti-Bacterial Agents/pharmacology , Drug Resistance, Bacterial , Gram-Negative Bacterial Infections/microbiology , Quinolones/pharmacology , Aeromonas/classification , Aeromonas/isolation & purification , Amino Acid Substitution/genetics , DNA Gyrase/genetics , DNA Topoisomerase IV/genetics , Dipeptides/metabolism , Feces/microbiology , Humans , Microbial Sensitivity Tests , Mutation, Missense , Nalidixic Acid/pharmacology , Plasmids
7.
Int. microbiol ; 13(3): 135-141, sept. 2010. tab
Article in Spanish | IBECS | ID: ibc-84637

ABSTRACT

Mutations in quinolone targets were studied together with quinolone efflux pump activation and plasmid-mediatedquinolone resistance determinants in nalidixic-acid-resistant isolates of Aeromonas caviae and Aeromonas veronii.Among 135 clinical Aeromonas spp. isolated from stools of patients with gastrointestinal symptoms, 40 nalidixic acid-resistantstrains belonging to A. caviae and A. veronii were selected and their susceptibility to different quinolones (ciprofloxacin,norfloxacin, ofloxacin) further evaluated. Susceptibility to nalidixic acid and ciprofloxacin in the presence/absence of Phe-Arg-β-naphthylamide was also determined. The 16 nalidixic-acid-resistant strains identified as A. caviae were more resistantthan the 24 A. veronii bv. sobria strains to ciprofloxacin, norfloxacin, and ofloxacin. All strains showed a mutation (single ordouble) at position 83 of the QRDR sequence of gyrA, with Ser-83 → Ile as the most frequent substitution. By contrast, nomutations were found at position 87 of gyrA. Double substitutions (GyrA-ParC) were detected in 50% of A. veronii bv. sobriaisolates and in 43.75% of A. caviae strains. Both species showed decreases in the MICs of ciprofloxacin. A qnrS gene wasfound in an A. caviae strain. Thus, in the two species of nalidixic-acid-resistant Aeromonas isolates examined, resistancemediated by efflux pumps contributed only slightly to ciprofloxacin resistance. While two isolates were positive for theaac(6′)-Ib gene, no -cr variants were detected (AU)


Subject(s)
Humans , Aeromonas , Anti-Bacterial Agents/pharmacology , Drug Resistance, Bacterial , Gram-Negative Bacterial Infections/microbiology , Quinolones/pharmacology , Aeromonas/classification , Aeromonas/isolation & purification , Amino Acid Substitution/genetics , Feces/microbiology , Microbial Sensitivity Tests
SELECTION OF CITATIONS
SEARCH DETAIL
...